Literature DB >> 23217584

Glaucoma and uveitis.

Sana S Siddique1, Ana M Suelves, Ujwala Baheti, C Stephen Foster.   

Abstract

Despite its relative rarity, uveitis is the third leading cause of preventable blindness worldwide. Glaucoma associated with uveitis is one of the most serious complications of intraocular inflammation. We review in detail the epidemiology and pathogenesis of uveitic glaucoma and the safety and efficacy of the current medical and surgical treatment modalities.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23217584     DOI： 10.1016/j.survophthal.2012.04.006

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  31 in total

1.  Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?

Authors:  Bogomil Voykov; Christoph Deuter; Manfred Zierhut; Martin Alexander Leitritz; Emmanuella Guenova; Emmanuella Guenova-Hötzenecker; Deshka Doycheva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

2.  Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.

Authors:  Masahide Kawamura; Masahiro Zako
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

3.  Long-term efficacy of deep sclerectomy in Posner-Schlossman syndrome.

Authors:  Fiamma Campana; Guido Caramello; Laura Dallorto; Teresa Rolle
Journal:  BMJ Case Rep       Date:  2015-01-23

Review 4.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

5.  Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation.

Authors:  Shawn M Iverson; Namita Bhardwaj; Wei Shi; Mitra Sehi; David S Greenfield; Donald L Budenz; Krishna Kishor
Journal:  Jpn J Ophthalmol       Date:  2015-02-17       Impact factor: 2.447

6.  Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.

Authors:  Sentaro Kusuhara; Atsuko Katsuyama; Wataru Matsumiya; Makoto Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-21       Impact factor: 3.117

7.  A generalised porous medium approach to study thermo-fluid dynamics in human eyes.

Authors:  Alessandro Mauro; Nicola Massarotti; Mohamed Salahudeen; Mario R Romano; Vito Romano; Perumal Nithiarasu
Journal:  Med Biol Eng Comput       Date:  2018-03-22       Impact factor: 2.602

8.  Trabeculectomy ab interno with the Trabectome® as a therapeutic option for uveitic secondary glaucoma.

Authors:  Alexandra Anton; Sonja Heinzelmann; Thomas Neß; Jan Lübke; Matthias Neuburger; Jens F Jordan; Thomas Wecker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-24       Impact factor: 3.117

9.  The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.

Authors:  Ufuk Elgin; Emine Sen; Kubra Ozdemir; Pinar Ozdal; Nilufer Berker
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

10.  Influence of optic disc leakage on objective optic nerve head assessment in patients with uveitis.

Authors:  Carsten Heinz; Katy Kogelboom; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-18       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.